[Thomson Reuters ONE] - Leiden, the Netherlands, March 28th, 2013. Biotech company Pharming Group NV ("Pharming") (NYSE Euronext: PHARM) announced today that it has received approval from the European Medicines Agency ...
You are receiving this email because you subscribed to this feed at blogtrottr.com.
No comments:
Post a Comment